Treatment of Bacterial Vaginosis With Oral Tinidazole
The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||A Phase III Randomized, Multi-Center, Double-Blind, Double-Dummy, Placebo-Controlled Treatment Trial of Bacterial Vaginosis With Tinidazole Oral Tablets.|
- Therapeutic efficacy
- Clinical efficacy
- Microbiological efficacy
|Study Start Date:||January 2005|
Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat bacterial vaginosis, one of the most common vaginal infections.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00229216
|United States, North Carolina|
|Duke University School of Medicine|
|Durham, North Carolina, United States, 27710|